Shanghai Haohai Biological Technology Co. Ltd Tangible Net Worth Ratio

Latest as of December 2025: 90.4%

Shanghai Haohai Biological Technology Co. Ltd tangible net worth ratio. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Tangible Net Worth Ratio of 90.4% as of December 2025. This metric is calculated by deducting intangible assets (€539.73 Million) from net assets (€5.60 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 5HB capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

90.4%
Tangible equity / total equity

Net Assets (Equity)

€5.60 Billion
EUR

Intangible Assets

€539.73 Million
Goodwill, patents, brand value

Total Assets

€6.72 Billion
EUR

Tangible Net Worth Ratio of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)

Tangible net worth ratio of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. This chart shows how Shanghai Haohai Biological Technology Co. Ltd's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 90.4%, reflecting net assets of €5.60 Billion with intangible assets of €539.73 Million EUR. See Shanghai Haohai Biological Technology Co short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai Haohai Biological Technology Co. Ltd Tangible Net Worth Ratio by Year (2016–2025)

Shanghai Haohai Biological Technology Co. Ltd tangible net worth ratio by year from 2016 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Shanghai Haohai Biological Technology Co stock valuation.

Year Tangible NW Ratio Net Assets (EUR) Intangible Assets Total Assets Change (pp)
2025 90.4% €5.60 Billion €539.73 Million €6.72 Billion ▲ +2.3 pp
2024 88.1% €5.92 Billion €705.10 Million €7.12 Billion ▲ +0.2 pp
2023 87.9% €6.02 Billion €729.07 Million €7.11 Billion ▲ +1.2 pp
2022 86.7% €5.90 Billion €783.53 Million €6.89 Billion ▼ -3.2 pp
2021 89.9% €6.06 Billion €613.40 Million €6.95 Billion ▼ -3.1 pp
2020 92.9% €5.73 Billion €404.33 Million €6.30 Billion ▲ +0.6 pp
2019 92.4% €5.65 Billion €430.61 Million €6.15 Billion ▲ +4.6 pp
2018 87.8% €3.84 Billion €467.12 Million €4.44 Billion ▲ +2.4 pp
2017 85.4% €3.37 Billion €490.15 Million €4.08 Billion ▼ -3.6 pp
2016 89.1% €2.99 Billion €326.29 Million €3.69 Billion —
pp = percentage points